(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) are a response to EGFR-tyrosine kinase inhibitor. However, a lack of sufficient tumor tissue has been a limitation for determining EGFR mutation status in clinical practice. The objective of this study was to pre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Guan, Jian, Xiao, Nan J., Chen, Min, Zhou, Wen L., Zhang, Yao W., Wang, Shuang, Dai, Yong M., Li, Lu, Zhang, Yue, Li, Qin Y., Li, Xiang Z., Yang, Mi, Wu, Hu B., Chen, Long H., Liu, Lai Y.
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2016
Témata:
5700
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265876/
https://ncbi.nlm.nih.gov/pubmed/27472739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004421
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky